/Investor DB

RiverVest Venture Partners — 2018 Investments

3 investments dated 2018 · listed companies and verified rows first · show all

Mirum Pharmaceuticalsmirumpharma.comin𝕏NASDAQ: MIRMSeries A · Nov 2018 · $120M

Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.

BiotechHealthtechSan Diego, US

Chris Peetz(Co-founder & Chief Executive Officer)inEric Bjerkholt(Executive Officer)inPeter Radovich(Executive Officer)in

BoardPatrick Heron(Director)inMichael Grey(Director)Timothy Walbert(Director)

Co-investorsChiesi VenturesFrazier Life SciencesLongitude CapitalMESA VERDE VENTURE PARTNERSNew Enterprise Associates (NEA)Pappas Capital+4 more

Smart Wiressmartwires.comMay 2018SEC filingmedium confidence

Smart Wires provides advanced power flow control technology for electric utilities and transmission operators, letting them redirect electricity away from constrained circuits to increase usable transfer capacity and strengthen grid reliability.

CleantechEnergyHardwareOakland, US

James C David(Executive Officer, Director)Woody Gibson(Executive Officer)Stewart Ramsay(Executive Officer, Director)

BoardAnthony Arnerich(Director)Frederick Buckman(Director)

Board seatJay Schmelter· per SEC Form D · $85.8M raise · filed Jan 2020

Co-investorsAlumni VenturesEnergy Transition Ventures3x5 Partners

Standard Bariatricsstandardbariatrics.cominJun 2018Acquired

Standard Bariatrics develops the Titan SGS™ Stapler, a specialized surgical device designed for sleeve gastrectomy procedures that creates consistent and symmetrical gastric pouches using an anatomy-based approach.

Medical Devices

Co-investorsArieal Southeast Angel PartnersCincyTechEmergent Medical Partners, LLPHatteras Venture PartnersJobsOhio VenturesRC Capital+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.